文献速递细胞病理与分子病理

滤泡性与嗜酸细胞性滤泡性甲状腺肿瘤的细胞病理学:Bethesda系统视角

Cytopathology of follicular and oncocytic follicular thyroid neoplasms: A Bethesda System perspective.
PubMed 文献 · Cancer Cytopathol · 2025-01-01

本文综述Bethesda甲状腺细胞病理学报告系统第三版中IV类滤泡性肿瘤(FN)及嗜酸细胞性滤泡性肿瘤(OFN)的诊断方法。强调需满足足够细胞量、符合肿瘤的结构特征及滤泡或嗜酸细胞形态学的最小诊断标准,并通过形态学与有限辅助检查排除常见鉴别诊断,以筛选适合诊断性甲状腺叶切除术的病例。

要点

  • FN诊断需满足足够细胞量、肿瘤性结构特征及滤泡/嗜酸细胞形态。
  • 需排除滤泡结节病、甲状旁腺采样、转移癌、NIFTP、髓样癌等鉴别诊断。
  • 严格筛选病例有助于确定诊断性甲状腺叶切除术的适宜性。

核心结论

  • FN与OFN的诊断应遵循最小标准并排除重要鉴别诊断,以优化甲状腺叶切除术的病例选择。

研究设计与样本

  • 综述性文章,基于Bethesda系统第三版对FN和OFN的细胞病理学诊断方法进行阐述。

主要发现

  • FN诊断不常作出,对病理学家可能具有挑战性。
  • FN和OFN的诊断需满足足够细胞量、肿瘤性结构特征及滤泡或嗜酸细胞形态。
  • 需通过形态学与有限辅助检查排除滤泡结节病、甲状旁腺采样、转移癌、NIFTP、髓样癌、某些乳头状癌亚型及淋巴细胞性甲状腺炎。

关键数值与推荐

  • FN诊断的最小标准:足够细胞量、符合肿瘤的结构特征、滤泡细胞或嗜酸细胞形态。
  • 需排除的鉴别诊断包括滤泡结节病、甲状旁腺采样、转移癌、NIFTP、髓样甲状腺癌、某些乳头状甲状腺癌亚型及淋巴细胞性甲状腺炎。

临床怎么用

  • 采用系统方法诊断FN和OFN,结合形态学与有限辅助检查排除鉴别诊断,以筛选适合诊断性甲状腺叶切除术的病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The third edition of The Bethesda System for Reporting Thyroid Cytopathology includes category IV, follicular neoplasm (FN), which is used to classify fine-needle aspirates of thyroid nodules that may correspond to invasive follicular-derived neoplasia other than papillary thyroid carcinoma. This diagnosis is infrequently rendered, and may represent a challenge for pathologists. This review presents a practical approach to FN and its subtype oncocytic follicular neoplasm (OFN). First, minimal criteria for the diagnosis must be achieved, namely sufficient cellularity, architectural features consistent with neoplasia, and follicular cell or oncocytic cytomorphology. Second, select diagnoses that are common or important differential diagnoses for FN or OFN must be ruled out, via a combination of morphological findings and limited ancillary tests, when available. These include follicular nodular disease, parathyroid sampling, metastatic carcinoma, noninvasive follicular thyroid neoplasm with papillary-like nuclear features, medullary thyroid carcinoma, certain subtypes of papillary thyroid carcinoma, and lymphocytic thyroiditis. This approach should allow for a careful selection of cases where diagnostic thyroid lobectomy is an appropriate therapeutic modality.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Lametti A, Brimo F, Kanber Y, et al. Cytopathology of follicular and oncocytic follicular thyroid neoplasms: A Bethesda System perspective. Cancer Cytopathol. 2025. PMID: 40272265. doi:10.1002/cncy.70016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。